Newest RATED A+ 2025/2026 NEW
Section 2: Pharmacology Basics
Il` Il` Il`
Chapter 1: Pharmacology & The Nursing Process
Il` Il` Il` Il` Il` Il`
• Subjective Data: Information gathered from the patient or their support system, including
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
health history, signs and symptoms (S/S), current medications, and the patient's ability to
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
access prescribed medications.
Il` Il` Il`
• Objective Data: Measurable signs detected by healthcare professionals (HCP), such as
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
vital signs (V/S), lab results, and health assessments.
Il` Il` Il` Il` Il` Il` Il` Il`
• Pre-administration Assessment: Critical steps include establishing baseline Il` Il` Il` Il` Il` Il`
measurements (e.g., blood pressure before administering lisinopril), anticipating adverse
Il` Il` Il` Il` Il` Il` Il` Il` Il`
effects (e.g., checking potassium levels before starting Lasix), identifying high-risk patients
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
(e.g., African Americans and ACE inhibitors), and determining the patient's self-care
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
capacity.
Il`
• Nursing Diagnosis: Essential for guiding the development of care plans, particularly in
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
relation to drug therapy, addressing issues like pain, confusion, and the need for health
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
education.
Il`
Pharmacokinetics
• Definition: The study of how the body affects a drug, encompassing absorption,
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
distribution, metabolism, and excretion (ADME).
Il` Il` Il` Il` Il`
• Absorption: The process by which a drug enters the bloodstream; influenced by Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
bioavailability and the first-pass effect, which can significantly reduce the amount of
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
active drug available.
Il` Il` Il`
• Distribution: Refers to how the drug is transported throughout the body, primarily via the Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
bloodstream, with albumin being the most common protein that carries drugs.
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
• Metabolism: Also known as biotransformation, it involves the chemical alteration of a Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
drug, primarily in the liver, affecting its efficacy and toxicity. Cytochrome P-450 enzymes
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
play a crucial role in this process.
Il` Il` Il` Il` Il` Il` Il`
, • Excretion: The elimination of drugs from the body, primarily through the kidneys, but also
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
via bile, sweat, saliva, and other routes.
Il` Il` Il` Il` Il` Il` Il`
Pharmacodynamics
• Definition: The study of the effects of drugs on the body, including mechanisms of action Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
and therapeutic effects.
Il` Il` Il`
• Dose-Response Relationship: Describes how the body's physiological response changes Il` Il` Il` Il` Il` Il` Il` Il`
with varying drug concentrations, determining the minimum effective concentration
Il` Il` Il` Il` Il` Il` Il` Il` Il`
(MEC) needed for a therapeutic effect.
Il` Il` Il` Il` Il` Il`
• Efficacy vs. Potency: Efficacy refers to the maximum effect a drug can produce, while
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
potency indicates the amount of drug needed to achieve a desired effect.
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
• Drug Half-Life: The time required for the concentration of the drug in the bloodstream to
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
reduce by half, influencing dosing schedules and therapeutic levels.
Il` Il` Il` Il` Il` Il` Il` Il` Il`
Drug Receptors and Interactions
Il` Il` Il`
• Agonists and Antagonists: Agonists activate receptors to produce a response, while
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
antagonists block receptor activation, preventing normal receptor function.
Il` Il` Il` Il` Il` Il` Il` Il`
• Drug-Drug Interactions: Can be additive (increased effect), synergistic (greater effect than
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
individual drugs), or antagonistic (one drug blocks the effect of another).
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
• Examples of Interactions: Desirable interactions include combining diuretics with beta-
Il` Il` Il` Il` Il` Il` Il` Il` Il`
blockers to lower blood pressure, while undesirable interactions may involve alcohol and
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
aspirin leading to increased bleeding risk.
Il` Il` Il` Il` Il` Il`
Chapter 3: Lifespan Considerations
Il` Il` Il`
Changes in Older Adults Il` Il` Il`
• Absorption: Changes include decreased hydrochloric acid production, delayed gastric Il` Il` Il` Il` Il` Il` Il` Il`
emptying, and reduced GI blood flow, affecting drug absorption.
Il` Il` Il` Il` Il` Il` Il` Il` Il`
• Distribution: Total body water decreases while fat content increases, leading to altered Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
drug distribution and potential toxicity due to reduced protein binding.
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
• Metabolism: Decreased liver size and blood flow can lead to slower drug metabolism, Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
increasing the risk of drug interactions and toxicity.
Il` Il` Il` Il` Il` Il` Il` Il`
• Excretion: Reduced glomerular filtration rate (GFR) in older adults heightens the risk of
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
drug accumulation and toxicity.
Il` Il` Il` Il`
, Section 3: Drugs Affecting the CNS
Il` Il` Il` Il` Il`
Chapter 12: CNS Depressants & Skeletal Muscle Relaxant Therapy
Il` Il` Il` Il` Il` Il` Il` Il`
• CNS Depressants: Medications that slow brain activity, used for moderate sedation;
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
examples include benzodiazepines like Diazepam, Lorazepam, and Midazolam.
Il` Il` Il` Il` Il` Il` Il` Il`
• Midazolam: Used for pre-operative and procedural sedation; rapid absorption and high Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
protein binding; potential adverse reactions include sedation and respiratory depression.
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
• Skeletal Muscle Relaxants: Used to relieve muscle spasms; Cyclobenzaprine (Flexeril) is a
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
common example, with rapid absorption and significant protein binding.
Il` Il` Il` Il` Il` Il` Il` Il` Il`
• Adverse Reactions and Contraindications: Both classes of drugs have specific
Il` Il` Il` Il` Il` Il` Il` Il` Il`
contraindications and interactions, such as with alcohol and other CNS depressants, which
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
can enhance sedation.
Il` Il` Il`
Chapter 16: Psychotherapeutic Drugs
Il` Il` Il`
Antidepressant and Mood Stabilizer Drug Therapy Il` Il` Il` Il` Il`
• SNRI (Duloxetine): Used for Major Depressive Disorder (MDD), Generalized Anxiety
Il` Il` Il` Il` Il` Il` Il` Il` Il`
Disorder (GAD), Social Anxiety Disorder, and pain management. It works by inhibiting the
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
reuptake of serotonin and norepinephrine, although the onset time is not specified.
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
• SSRIs (Sertraline, Citalopram, Fluoxetine, Paroxetine): Commonly prescribed for
Il` Il` Il` Il` Il` Il` Il`
depression, anxiety, and PTSD. Side effects include sexual dysfunction, weight gain, and
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
insomnia, with an onset of about 1 week. They selectively block the reuptake of serotonin,
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
enhancing mood.
Il` Il`
• Atypical Antidepressants (Bupropion): Effective for MDD, sleep disorders, and smoking
Il` Il` Il` Il` Il` Il` Il` Il` Il`
cessation. Side effects include insomnia, headache, and weight loss, with an onset of 1-2
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
weeks. They affect 1-2 of the 3 neurotransmitters: serotonin, norepinephrine, and
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
dopamine.
Il`
• Mood Stabilizers: Primarily used in the treatment of Bipolar Disorder. Key drugs include
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
Lithium, Carbamazepine, Valproic Acid, Divalproex, and Lamotrigine. Lithium has a short
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
half-life and a high risk for toxicity, requiring careful dosing and monitoring.
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
• Lithium: Well absorbed in the GI tract, distributed evenly in body tissues, not metabolized,
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
and excreted in urine. It alters sodium ion transport, with an onset of 5-7 days.
Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il` Il`
Antipsychotic Drug Therapy Il` Il`